Abstract:Background Data on sexual function in patients with adrenal insufficiency are scarce and largely controversial. Objectives To investigate sexual dysfunction in patients with primary and secondary adrenal insufficiency and the effects of switching to once‐daily dual‐release hydrocortisone on sexual function in outcome assessors blinded, randomized, multicenter, active comparator clinical trial. Materials and methods Eighty‐nine adrenal insufficiency patients on conventional, multiple daily doses of glucocorticoid replacement, enrolled in the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent in hypocortisolism (DREAM) trial, were randomly assigned to continue their therapy or to switch to an equivalent dose of dual‐release hydrocortisone. Sixty‐three patients (34 women) consented to sex steroid measurements and questionnaires completion for quality of life (Addison's disease‐specific quality‐of‐life questionnaire) and sexual function evaluation (female sexual function index for women, International Index of Erectile Function‐Erectile Function for men) at baseline and 24 weeks after randomization. Results At baseline, sexual dysfunction was observed in 41% of women and 59% of men with adrenal insufficiency. In both sexes, no associations were found between sexual function and hormone levels, whereas Addison's disease‐specific quality‐of‐life questionnaire total and fatigue domain scores positively correlated with total female sexual function index and International Index of Erectile Function‐Erectile Function scores. At 24 weeks, there was no significant difference either in sexual function or sex steroid levels between study groups. In the dual‐release hydrocortisone group, the variation in the female sexual function index desire domain score was positively associated with the change in Addison's disease‐specific quality‐of‐life questionnaire's symptom domain score (ρ = 0.478, p = 0.045). Discussion Sexual dysfunction is common in adrenal insufficiency patients and is likely explained by multiple factors. dual‐release hydrocortisone treatment is not directly associated with sexual function improvement, but an indirect effect mediated by quality‐of‐life amelioration cannot be excluded.

The effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments

Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency

Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial

Effect and its clinical significance of different dose of glucocorticoids on inflammation mediators in patients with acute exacerbation of chronic obstructive pulmonary diseases

Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular and bone outcomes in adrenal insufficiency: a 10-year study

Therapeutic innovations in endocrine diseases - Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?

A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy

The Effects of Burst Steroid Therapy on Short-term Decongestion in Acute Heart Failure Patients With Pro-inflammatory Activation: A Post Hoc Analysis of the CORTAHF Randomized, Open-label, Pilot Trial

The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers

Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review

Effect of mild cortisol cosecretion on body composition and metabolic parameters in patients with primary hyperaldosteronism

Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue

Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?

A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic–Pituitary–Adrenal Axis

Eight Weeks of Lifestyle Change: What are the Effects of the Healthy Lifestyle Community Programme (Cohort 1) on Cortisol Awakening Response (CAR) and Perceived Stress?

Advancements in Cortisol Detection: From Conventional Methods to Next-Generation Technologies for Enhanced Hormone Monitoring

The effect of different treatment modalities on oxidative stress in COPD

Effects of cortisol administration on heart rate variability and functional connectivity across women with different depression histories

Steroid Profiling and Circadian Cortisol Secretion in Patients With Mild Autonomous Cortisol Secretion: A Cross-sectional Study

Clinical Utilization of Stress Dose Hydrocortisone in Adult Patients with Septic Shock: A Retrospective Observational Study at a Large Academic Medical Center

A Multivariate Study of Simultaneous Escape from Suppression by Dexamethasone of Urinary Free Cortisol, Plasma Cortisol, Adrenocorticotropic Hormone and Beta-Endorphin in Melancholic Patients.